Pulmonx Co. (NASDAQ:LUNG) Receives Consensus Recommendation

Shares of Pulmonx Co. (NASDAQ:LUNG – Get Free Report) have received an average rating of “Moderate Buy” from the six brokerages that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year target price among […]

Related Keywords

France , French , David Aaron Lehman , Piper Sandler , Stifel Nicolaus , Citigroup , Goldman Sachs Group Inc , Securities Exchange Commission , Nasdaq , Barclays Plc , Wells Fargo Company , Vanguard Group Inc , Pulmonx Co , Capital Partners , Allspring Global Investments Holdings , Pulmonx Corporation , Get Free Report , Exchange Commission , General Counsel David Aaron Lehman , Global Investments Holdings , Sachs Group , Get Free , Zephyr Endobronchial Valve , Chartis Pulmonary Assessment System , Pulmonx Daily , Pulmonx , Nasdaq Lung , Lung , Medical , Ratings , Consensus ,